Start using it three days before your hospital admission, continue the day you are admitted, and for three days after your procedure.
Notes
- The decision to eradicate throat carriage in children should be made on an individual basis by the team looking after the patient and as required in consultation with the IPCT, as administration could be difficult due to the age and cooperation of the child. Nasal ointment and throat spray should not be given to small babies if there is a risk the treatment will occlude the airway.
- Neonates should always be discussed on an individual basis. A neonate is defined as being less than four weeks post term equivalent.
- Treatment should not be given for more than three courses to individual patients in any one episode to avoid the development of resistance and should not be given for courses longer than those shown in the table unless agreed by a Microbiologist.
- Eradication Therapy is not always successful. It is most likely to be successful in patients with only nasal carriage. Contact the IPCT for advice on the management of persistent carriage of MRSA.